Sign inOpen the app
Artwork for BioBoss
Science

BioBoss

John Simboli

BioBoss is a podcast about leadership in the biopharma community. Hear directly from the founders and CEOs of today's most innovative companies. Listen in as Wyant Simboli Principal and branding veteran John Simboli poses the questions "What drives you? How do you create change? Why should people care?" to biopharma leaders and hear insights on this rapidly developing field.
SubscribeListen in podnodRSS feedShow website
  • 98 episodes
  • Updated Wednesday

Episodes98

Newest first
  • Dec 3, 2022 · 41 min

    Luca Benatti: CEO of EryDel

    Luca Benatti, CEO of EryDel, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how EryDel is working to develop specialized therapies for the treatment of rare diseases by using the patient’s own blood.

  • Oct 8, 2022 · 46 min

    Paul Radspinner: Founder and CEO of Flugen

    Paul Radspinner, founder and CEO of Flugen, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Flugen is working to develop a more effective vaccine in the fight against influenza and respiratory disease.

  • Sep 19, 2022 · 42 min

    Jesús Martin-Garcia: CEO of GeNeuro

    Jesús Martin-Garcia, CEO of GeNeuro, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Geneuro is working to develop treatments against neurological disorders and autoimmune diseases by neutralizing causal factors encoded by Human Endogenous Retroviruses.

  • Aug 17, 2022 · 34 min

    Cliff Stocks: Founder and CEO of OncoResponse

    Cliff Stocks, founder and CEO of OncoResponse speaks with BioBoss host John Simboli. Hear Cliff’s insights about leadership in biopharma and how OncoResponse is working to identify fully human monoclonal antibodies as therapeutics for the treatment of cancer.

  • Jul 16, 2022 · 41 min

    Brian Finrow: Co-Founder and CEO of Lumen Bioscience

    Brian Finrow, Co-founder and CEO of Lumen Bioscience, speaks with BioBoss host and biopharma branding veteran John Simboli. Hear Brian’s thoughts about leadership and how Lumen Biosciences is working to unlock the full potential of biologic drugs, whose promise has been held back by the lack of scalable technology.

  • May 21, 2022 · 30 min

    Andrew Hall: CEO of IMV Inc.

    Hear Andrew speak with BioBoss host John Simboli about leadership in biopharma and how IMV is working on advancing a portfolio of therapies based on the Company’s immune-educating platform.

  • Apr 18, 2022 · 40 min

    Kevin Lee: CEO of Bicycle Biotherapeutics

    Kevin Lee, CEO of Bicycle Therapeutics, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Bicycle Therapeutics is working on developing a new class of medicines, called Bicycles, for diseases that are underserved by existing therapeutics.

  • Mar 26, 2022 · 27 min

    Reenie McCarthy: CEO of Stealth BioTherapeutics

    BioBoss host John Simboli speaks with Reenie McCarthy, CEO of Stealth BioTherapeutics, headquartered in Needham, MA.. Hear Reenie's thoughts about leadership in biopharma and how Stealth Biotherapeutics is working on developing therapies to treat the mitochondrial dysfunction associated with genetic mitochondrial diseases and many common age-related diseases.

  • Feb 5, 2022 · 41 min

    Yochi Slonim: Founder and CEO of Anima Biotech

    BioBoss host John Simboli speaks with Yochi Slonim, founder and CEO of Anima Biotech, headquartered in Boston with R&D in Tel Aviv.. Hear Yochi's thoughts about leadership in biopharma and how Anima Biotech is working on a novel approach for the discovery of small molecules that selectively control mRNA translation as a new strategy against undruggable proteins.

  • Jan 8, 2022 · 32 min

    Clive Richardson: CEO of Akari Therapeutics

    BioBoss host John Simboli speaks with Clive Richardson, CEO of Akari Therapeutics, headquartered in London with offices in New York. Hear Clive's thoughts about leadership in biopharma and how Akari Therapeutics is working to develop life-transforming treatments for autoinflammatory diseases involving the complement and leukotriene pathways

  • Dec 28, 2021 · 1 min

    Welcome to Season 4 of BioBoss

    BioBoss podcast host John Simboli reflects on the success of seasons 1, 2 and 3 and welcomes listeners to listen in on his conversations about leadership with biopharma founders and CEOs in BioBoss season 4.

  • Dec 4, 2021 · 38 min

    Stefan König: CEO of George Medicines

    BioBoss host John Simboli speaks with Stefan König , CEO of George Medicines, headquartered in London. Hear Stefan’s thoughts about leadership in biopharma and how George Medicines is working to extend and improve the lives of people suffering from the world’s leading causes of death and disability—including hypertension, cardiovascular disease and type 2 diabetes

  • Oct 29, 2021 · 38 min

    Derek Maetzold: CEO of Castle Biosciences

    Derek Maetzold, CEO of Castle Biosciences shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Castle is leveraging its expertise in cancer genomics and the use of artificial intelligence to improve patient outcomes.

  • Oct 2, 2021 · 34 min

    Bob Cobuzzi: CEO of Diffusion Pharmaceuticals

    Bob Cobuzzi, Chief Executive Officer of Diffusion Pharmaceuticals,speaks with BioBoss John Simboli about leadership and how Diffusion Pharmaceuticals is working to develop novel therapies that enhance the body’s ability to deliver oxygen to the areas where it is needed most.

  • Sep 12, 2021 · 39 min

    Panna Sharma: CEO of Lantern Therapeutics

    Panna Sharma, CEO of Lantern Pharma, headquartered in Dallas, Texas, shares his thoughts with BioBoss host John Simboli about leadership and how Lantern is working at the intersection of artificial intelligence, genomics and machine learning to advance precision oncology therapies.

  • Jul 31, 2021 · 44 min

    Nandan Padukone: CEO of IM Therapeutics

    Nandan Padukone, CEO of IM Therapeutics, headquartered in Woburn, Massachusetts, shares his thoughts with BioBoss host John Simboli about leadership and how IM Therapeutics is targeting the root cause of autoimmunity with therapeutic design directed at human leukocyte antigens.

  • Jul 10, 2021 · 39 min

    Matthew Gline: CEO of Roivant Sciences

    "I think I've always found motivation from being able to take a highly technical topic and dig in. I'm never the person that knows most about the topic. But I strive to be like the person who knows third or fourth most about whatever topic is going." – Mathew Gline: CEO of Roivant Sciences

  • May 30, 2021 · 31 min

    Koen De Witte: Managing Director of ReMYND

    Koen De Witte, managing director of reMYND NV, headquartered in Leuven, Belgium, shares his thoughts with BioBoss host John Simboli about leadership and how reMYND is advancing treatments for Alzheimer’s, diabetes and other diseases caused by cellular dysfunction.